CRIS Current Research Information System

FABBRI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.823
NA - Nord America 6.248
EU - Europa 4.193
SA - Sud America 571
AF - Africa 315
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 8
Totale 18.178
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.139
SG - Singapore 2.033
CN - Cina 1.900
VN - Vietnam 1.176
IT - Italia 774
GB - Regno Unito 754
FR - Francia 634
DE - Germania 596
HK - Hong Kong 565
SE - Svezia 500
BR - Brasile 443
IN - India 336
KR - Corea 260
RU - Federazione Russa 218
IE - Irlanda 169
JP - Giappone 144
NL - Olanda 94
AT - Austria 79
ZA - Sudafrica 78
ID - Indonesia 74
CI - Costa d'Avorio 64
SC - Seychelles 64
FI - Finlandia 59
AR - Argentina 55
UA - Ucraina 49
EE - Estonia 48
JO - Giordania 48
TG - Togo 48
CA - Canada 45
BD - Bangladesh 39
MX - Messico 38
IQ - Iraq 37
PL - Polonia 35
BG - Bulgaria 32
CH - Svizzera 31
PH - Filippine 30
TR - Turchia 27
TH - Thailandia 25
PK - Pakistan 22
CO - Colombia 20
EC - Ecuador 20
AU - Australia 18
BE - Belgio 18
ES - Italia 17
GR - Grecia 15
SA - Arabia Saudita 15
UZ - Uzbekistan 15
IL - Israele 14
CZ - Repubblica Ceca 11
MA - Marocco 11
DK - Danimarca 10
TW - Taiwan 10
MY - Malesia 9
TN - Tunisia 9
VE - Venezuela 9
AZ - Azerbaigian 8
EG - Egitto 8
JM - Giamaica 8
ET - Etiopia 7
EU - Europa 7
PY - Paraguay 7
HU - Ungheria 6
LB - Libano 6
NO - Norvegia 6
PE - Perù 6
CL - Cile 5
LT - Lituania 5
PA - Panama 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
GH - Ghana 4
HR - Croazia 4
IR - Iran 4
KE - Kenya 4
NP - Nepal 4
SY - Repubblica araba siriana 4
AL - Albania 3
BW - Botswana 3
KG - Kirghizistan 3
NG - Nigeria 3
SI - Slovenia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
AD - Andorra 1
Totale 18.158
Salva come PNG Salva come JPEG
Città #
Singapore 1.356
Fairfield 667
Southend 633
Ashburn 625
Hefei 594
Hong Kong 524
San Jose 443
Santa Clara 323
Seattle 289
Woodbridge 286
Cambridge 278
Hanoi 262
Ho Chi Minh City 262
Seoul 252
Wilmington 249
Chandler 243
Houston 229
Princeton 214
Ann Arbor 178
Bologna 176
Boardman 175
Beijing 171
Dublin 166
Lauterbourg 154
Dallas 151
Los Angeles 141
Tokyo 127
Dong Ket 104
Council Bluffs 88
Frankfurt am Main 82
Abidjan 64
Buffalo 64
Westminster 62
San Diego 58
Bengaluru 57
Nanjing 57
Haiphong 53
Padova 52
Redondo Beach 50
Vienna 49
Jakarta 48
Lomé 48
Amman 46
Berlin 46
Rome 46
Da Nang 42
New York 42
Milan 41
São Paulo 40
Turin 40
Chicago 36
Shenyang 36
Helsinki 35
Guangzhou 34
Shanghai 33
Nuremberg 32
Jinan 30
Saint Petersburg 30
Sofia 29
The Dalles 28
London 26
Olalla 25
Paris 23
Bern 22
Hebei 22
Mülheim 22
Tianjin 22
Warsaw 22
Orem 21
Tongling 21
Munich 20
Nanchang 20
North Charleston 20
Baghdad 19
Boston 19
Bühl 19
Des Moines 19
Changsha 18
Lappeenranta 18
Montreal 18
Naples 18
Phoenix 18
Wuhan 17
Xi'an 17
Hangzhou 15
Biên Hòa 14
Brasília 14
Hải Dương 14
Jiaxing 14
Walnut Creek 14
Amsterdam 13
Chennai 13
Falkenstein 13
Palermo 13
Rio de Janeiro 13
Chongqing 12
Ha Long 12
Jacksonville 12
Redmond 12
Antwerpen 11
Totale 11.465
Salva come PNG Salva come JPEG
Nome #
Genetica dei comportamenti impulsivo-aggressivi: possibile applicazione in psichiatria forense? 442
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone 352
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 223
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 220
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 214
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 208
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors 208
A model to investigate SNPs' interaction in GWAS studies 196
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 194
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial 178
Progress and prospects in pharmacogenetics of antidepressant drugs 178
Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder 175
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: A 6-month, open-label, randomized controlled pilot trial 173
TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. 170
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial 169
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response 166
Neuronal cell adhesion genes and antidepressant response in three independent samples 164
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 161
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials 161
Anhedonia is associated with a specific depression profile and poor antidepressant response 160
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance 160
Epigenetic basis of psychiatric disorders: a narrative review 158
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 151
Clinical features and drug induced side effects in early versus late antidepressant responders. 149
Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance 149
HTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: A meta-analysis 148
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. 148
Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR(⁎)D. 147
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders 146
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 144
Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients 144
The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives 143
Anxiety disorders and age-related changes in physiology 142
Pharmacogenetics in major depression: a comprehensive meta-analysis. 141
Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism. 141
Genome-wide association study of antidepressant response: Involvement of the inorganic cation transmembrane transporter activity pathway 141
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study 141
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study 138
No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression. 137
HTR1A gene polymorphisms and 5-HT1A receptor partial agonist antipsychotics efficacy in Schizophrenia 137
Predictors of switch from depression to mania in bipolar disorder 136
Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care data 135
Genetic basis of Bipolar disorder 135
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment. 134
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts 133
Genetics of serotonin receptors and depression: state of the art. 133
Pharmacogenetics of antidepressants. 132
Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials 131
Pharmacogenetics in Psychiatry 131
Mechanisms of antidepressant action: an integrated dopaminergic perspective. 130
Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation 130
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs 127
Schizophrenia-Like Symptoms in Narcolepsy Type 1: Shared and Distinctive Clinical Characteristics 126
Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients 125
Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder 125
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression 123
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses 122
Genetics of resilience: Implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression 122
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideation 121
Shared genetics among major psychiatric disorders. 121
Genetics of long-term treatment outcome in bipolar disorder 121
Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder 121
Comparison of Mortality Rates between Italian and Foreign-born Patients with Alcohol Use Disorders 121
Pharmacogenetics of antidepressant response. 119
Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: Common and specific effects of key regulators of fat-mass homoeostasis genes 119
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 118
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies 118
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples 117
Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder 116
Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank 115
The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review 115
DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy 115
Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research. 114
Identifying the Common Genetic Basis of Antidepressant Response 113
Age as a moderating factor of treatment resistance in depression 113
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation? 113
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder 112
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder 112
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies 112
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia 111
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder 111
Genetic variants associated with psychotic symptoms across psychiatric disorders 111
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns 110
Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder 109
Mirtazapine blood levels and antidepressant response 108
Refining prediction in treatment-resistant depression: Results of machine learning analyses in the TRD III sample 108
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries 107
Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications 107
Pharmacogenetics and depression: A critical perspective 107
Genetics in psychiatry: Methods, clinical applications and future perspectives 106
Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report 106
Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials 105
Clinical, demographic, and genetic risk factors of treatment-attributed suicidality in >10,000 Australian adults taking antidepressants 104
Correlation between emotion dysregulation and mood symptoms of bipolar disorder: A systematic review and meta-analysis 103
Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression 103
Biomarkers of treatment-resistant schizophrenia: A systematic review 101
Is Pharmacogenetics Useful in Antidepressant Treatment? 101
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression 101
Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice 100
The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank 99
Totale 14.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.310
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.310
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021368 0 0 0 0 0 0 0 0 0 39 24 305
2021/20221.727 122 85 82 52 154 122 48 256 75 140 311 280
2022/20231.881 170 229 118 176 111 149 111 142 344 54 164 113
2023/2024696 46 115 53 63 45 84 69 62 30 68 38 23
2024/20253.450 74 373 220 221 531 215 249 116 117 258 322 754
2025/20267.378 589 977 964 642 640 382 993 407 1.297 487 0 0
Totale 18.594